Literature DB >> 9874101

Observations on thermostable subpopulations of the unconventional agents that cause transmissible degenerative encephalopathies.

D M Taylor1, K Fernie, I McConnell, P J Steele.   

Abstract

When scrapie agent is exposed to partially inactivating autoclave cycles, the fraction of infectivity that survives remains thermostable during relatively long periods of autoclaving. This resistant subpopulation can also be differentiated from the main population by its prolonged incubation periods in assay animals, compared with control material. Stabilisation of this subpopulation may occur through the smearing and drying of infected tissue that can occur prior to autoclaving, in which the disease-specific form of PrP protein (PrP(Sc)) could become rapidly heat-fixed. This may paradoxically be what protects this fraction of PrP(Sc) from further inactivation during autoclaving. Data are presented showing that the thermostability acquired by the resistant subpopulation is a stable characteristic; autoclaving for a second time results in very little further loss of infectivity. These observations suggest that inactivation procedures that do not involve rapid and effective fixation of PrP(Sc) may be better candidates for dealing effectively with scrapie-like agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9874101     DOI: 10.1016/s0378-1135(98)00257-0

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  10 in total

1.  Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces.

Authors:  Julie Ann Edgeworth; Graham S Jackson; Anthony R Clarke; Charles Weissmann; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

2.  Insights into prion biology: integrating a protein misfolding pathway with its cellular environment.

Authors:  Susanne DiSalvo; Tricia R Serio
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

3.  Coinfecting prion strains compete for a limiting cellular resource.

Authors:  Ronald A Shikiya; Jacob I Ayers; Charles R Schutt; Anthony E Kincaid; Jason C Bartz
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

4.  Comparative study of surgical instruments from sterile-service departments for presence of residual gram-negative endotoxin and proteinaceous deposits.

Authors:  I P Lipscomb; A K Sihota; C W Keevil
Journal:  J Clin Microbiol       Date:  2006-08-23       Impact factor: 5.948

5.  Management of neurosurgical instruments and patients exposed to Creutzfeldt-Jakob disease.

Authors:  Ermias D Belay; Jennifer Blase; Lynne M Sehulster; Ryan A Maddox; Lawrence B Schonberger
Journal:  Infect Control Hosp Epidemiol       Date:  2013-10-24       Impact factor: 3.254

Review 6.  Mammalian prions and their wider relevance in neurodegenerative diseases.

Authors:  John Collinge
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

Review 7.  Environmental and host factors that contribute to prion strain evolution.

Authors:  Jason C Bartz
Journal:  Acta Neuropathol       Date:  2021-04-25       Impact factor: 17.088

8.  A standardized comparison of commercially available prion decontamination reagents using the Standard Steel-Binding Assay.

Authors:  Julie Ann Edgeworth; Anita Sicilia; Jackie Linehan; Sebastian Brandner; Graham S Jackson; John Collinge
Journal:  J Gen Virol       Date:  2010-11-17       Impact factor: 3.891

9.  Rapid assessment of bovine spongiform encephalopathy prion inactivation by heat treatment in yellow grease produced in the industrial manufacturing process of meat and bone meals.

Authors:  Miyako Yoshioka; Yuichi Matsuura; Hiroyuki Okada; Noriko Shimozaki; Tomoaki Yamamura; Yuichi Murayama; Takashi Yokoyama; Shirou Mohri
Journal:  BMC Vet Res       Date:  2013-07-09       Impact factor: 2.741

Review 10.  A closer look at prion strains: characterization and important implications.

Authors:  Laura Solforosi; Michela Milani; Nicasio Mancini; Massimo Clementi; Roberto Burioni
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.